AZoNano on MSN

New 3D-Printable Bioactive Glass for Bone Repair

Researchers, reporting in ACS Nano, developed a 3D-printable bioactive glass that functions effectively as a bone replacement ...
EuropaWire

AstraZeneca and Daiichi Sankyo’s Enhertu-based regimen shows 44% risk reduction and over three-year PFS in HER2-positive metastatic breast cancer

AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application for Enhertu plus pertuzumab has been accepted for Priority Review b ...